Single Versus Multiple Injection Ultrasound Guided Paravertebral Blocks

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT02852421
Collaborator
(none)
70
2
2
21
35
1.7

Study Details

Study Description

Brief Summary

Paravertebral block (PVB) has been shown to provide excellent analgesia for major breast surgeries resulting in reduced narcotic consumption, reduced nausea, improved quality of recovery, reduced chronic pain and possibly reduced metastasis with breast cancer. Traditionally, PVB is done by multiple injections below T1-T5 transverse processes. With multiple injections, the risk is increased for a pleural, an intraneural, and/or an intravascular injection. Recently, ultrasonography is being used to facilitate PVB. The use of ultrasound imaging enables real-time needle visualization during the procedure. This may improve efficacy and reduce the chances of complication like pneumothorax. Currently, there are no data comparing ultrasound-guided single injection technique with multiple injections technique with regards to extent of spread for PVB. Our objective is to investigate the extent of dermatomal spread of PVB when equal volumes of local anesthetic are injected at one versus five paravertebral sites for patients undergoing major breast surgery. In addition, the investigators wish to compare the performance time and duration of analgesia.

Methodology: After local REB approval, 72 patients undergoing a unilateral mastectomy with or without axillary node dissection will be randomized to receive either single or multiple injections PVB. The PVB will be performed in prone position under real-time ultrasound guidance using a para-sagittal approach.The patients in single injection group will receive single injection PVB at T3-T4 level with 25 ml of 0.5% ropivacaine and four subcutaneous sham injections. Patients in the multiple injection group will receive five injections of PVB from T1 to T5 level. 5 ml of 0.5% ropivacaine will be injected at each level. Pleural drift will be used as a sign of correct needle tip location and local anaesthetic spread. The pinprick method will be used to assess the extent of dermatomal blockade, 20 minutes following the completion of procedure. All patients will receive a standardized general anesthesia for the surgery. Any adverse events including pneumothorax, epidural spread, LA toxicity/seizure, total spinal, will be recorded.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Single injection paravertebral block
  • Procedure: Multiple injection paravertebral blocks
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Randomized Prospective Study to Evaluate Efficacy and Safety of Single Versus Multiple Injection Ultrasound Guided Paravertebral Blocks for Breast Surgery
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
May 1, 2015
Actual Study Completion Date :
May 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Multiple injection paravertebral blocks

Patients in this group will receive five injections of paravertebral blocks from T1 to T5 level. 5 ml of 0.5% "ropivacaine" was injected at each level.

Procedure: Multiple injection paravertebral blocks
Patients in the multiple injection group will receive five injections of paravertebral blocks from T1 to T5 level. 5 ml of 0.5% "ropivacaine" was injected at each level.

Experimental: Single injection paravertebral block

Patients in single injection group will receive single injection paravertebral blocks at T3-T4 level with 25 ml of 0.5% "ropivacaine" and four subcutaneous sham injections.

Procedure: Single injection paravertebral block
The patients in single injection group will receive single injection paravertebral block at T3-T4 level with 25 ml of 0.5% "ropivacaine" and four subcutaneous sham injections

Outcome Measures

Primary Outcome Measures

  1. Sensory dermatomal spread [20 minutes]

    20 minutes after block performance

Secondary Outcome Measures

  1. Time to performance of procedure [Duration of procedure]

  2. Cephalic and caudal dermatomal spread [20 minutes after block performance]

  3. Incidence of complication [24 hours]

    Follow-up phone call

  4. VAS pain scores in PACU [6 hours]

    During PACU stay

  5. Duration of self-reported numbness at the surgical site [24 hours]

    At follow-up phone call

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Females, age 18 to 80 years, scheduled to receive unilateral mastectomy surgery, with or without axillary node dissection

  • Able to give informed consent

  • Able to cooperate with study process

  • Availability of home telephone.

Exclusion Criteria:
  • Patient refusal or lack of informed consent

  • allergy to local anesthetic and other medications used in the study

  • Bilateral mastectomies

  • Coexisting hematological disorder or with deranged coagulation parameters

  • Pre-existing major organ dysfunction such as hepatic and renal failure

  • Significant thoracic kyphoscoliosis

  • History of previous thoracic surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 St. Joseph's Health Care London Ontario Canada N6A 4V2
2 London Health Sciences Centre University Hospital London Ontario Canada N6A 5A5

Sponsors and Collaborators

  • Lawson Health Research Institute

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sugantha Ganapathy, Professor, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT02852421
Other Study ID Numbers:
  • 17477
First Posted:
Aug 2, 2016
Last Update Posted:
Aug 16, 2016
Last Verified:
Aug 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 16, 2016